
Stay ahead with the latest in HEOR, Global Market Access, health policy, innovative tech, and groundbreaking research. Brought to you by @Syenza_Corp
Global
Joined March 2017
- Tweets3.5K
- Following4.3K
- Followers4.5K
- Likes3.2K
FDA's complete response letter for ivonescimab: 257 of 275 PFS events (93%) came from patients in China. It also cites a modest PFS gain, no significant OS benefit and benefit-risk, and asks for a new multiregional trial. Why it matters: trial geography now shapes US approval.
1
1
76
The four reasons in the letter, and what FDA asks Summit to do next: news.syenza.com/ivonescimab-…
10
Five countries are named for SADC group contracting of medicines: South Africa, Mozambique, Lesotho, Seychelles and Tanzania. The pooled procurement Charter was signed in Durban on 12 Nov. No prices or start date yet. For HTA teams: how does it feed national listing?
1
175
Full article: news.syenza.com/sadc-pharmac…
4
🔍 Can comparative effectiveness research (CER) make drug pricing fairer and more evidence-driven?
This article explains how integrating CER into pricing frameworks can align prices with real-world value.
Read the full article: news.syenza.com/integration-…
1
20
Are formulary changes finally widening access to GLP‑1 therapies? 💊📈
Recent formulary updates are expanding payer coverage and easing utilization controls for GLP‑1 medications ...
Read the full article: news.syenza.com/expanded-glp…
16
Could an implanted brain-computer interface restore movement for people with spinal cord injuries? 🧠 A recent regulatory approval for an invasive BCI ....
Read the full article: news.syenza.com/invasive-bra…
#SyenzaNews #MedTech #medicaldevices #innovation #healthcarepolicy
2
45
South African health suppliers face mounting compliance pressures under the 2026 Preferential Procurement Regulations. 📋
news.syenza.com/procurement-…
28
New post: Advancing Subcutaneous Diuretic Therapy for Heart Failure...
Could subcutaneous diuretic therapy keep heart failure patients out of hospital? 💡
Read more: news.syenza.com/advancing-su…
1
24
New post: Advancing Supply Chain Resilience in Europe’s Off-Patent ...
Concerned about recurring shortages of off‑patent medicines in Europe? 🛡️💊
Read more: news.syenza.com/supply-chain…
14
Can CEE close the East–West healthcare investment gap? 📈🌍 This analysis pinpoints the causes. Read more: news.syenza.com/closing-east…
1
19
Advancing Access: Generic Dapagliflozin Approval. 💊📉Read more: news.syenza.com/advancing-ac…
1
47
Can the FDA’s Accelerated Approval pathway deliver faster access without compromising evidence ... Read more: news.syenza.com/fda-accelera…
8
🔍 Do amyloid‑beta drugs meaningfully slow Alzheimer’s — or do harms and costs outweigh the modest gains. Read more: news.syenza.com/amyloid-beta…
25
New Danish study: no link between prenatal acetaminophen and autism — what does this mean? 💊🔎Read more: news.syenza.com/prenatal-ace…
5
Can community-led, low-cost interventions close the hypertension gap in underserved populations? 🩺🌍
Read more: news.syenza.com/hypertension…
4
New post: Could strategic partnerships be the key to widening access to long‑acting lenacapavir for HIV preven Read more: news.syenza.com/hiv-preventi…
19
New post: Antimicrobial Resistance Art. What happens when art meets antimicrobial resistance? 🎨🔬
Read more: news.syenza.com/antimicrobia…
1
23
Can pharma-led community programs help close global health gaps? 🌍🤝 Novartis is expanding ... Read more: news.syenza.com/novartis-exp…
16
New post: Advancements in Pulsed Field Ablation,
Varipulse Pro — newly launched. Read more: news.syenza.com/pulsed-field…
127